Skip to main content

Select Drug Profiles

The Spectrum of Agitation Associated with Schizophrenia and Bipolar Disorder

Socioeconomic Burden of Chronic Pain

Sabby Muneer, PhD

Addressing the Socioeconomic Burden of Chronic Pain

Jennifer M. Hah, MD, MS

Reducing the Negative Effects of Opioids While Adequately Managing Pain

Paul M. Hamrah, MS, PharmD

The Socioeconomic Burden of Patients with Chronic Pain

Gary M. Owens, MD

New Perspectives in the Treatment of Opioid-Induced Respiratory Depression

FDA Approves New Injectable Drug to Treat Schizophrenia

David B. Nash, MD, MBA

Optimizing Rheumatoid Arthritis Therapy: Using Objective Measures of Disease Activity to Guide Treatment

Gary M. Owens, MD

Stakeholder Perspective

Closing Gaps in Health Plan Performance with Stakeholder Collaboration

by F. Randy Vogenberg, PhD, FASHP

Evaluating the Expected Costs and Budget Impact of Interventional Therapies for the Treatment of Chronic Venous Disease

Rashad Carlton, PharmD, MSPH, Rajiv Mallick, PhD, Chelsey Campbell, PharmD, MBA, Aditya Raju, MS, BPharm, Thomas O'Donnell, MD, Michael Eaddy, PharmD, PhD, Michael Eaddy, PharmD, PhD, Michael F. Murphy, MD, PhD

Stakeholder Perspective

A Teachable Moment in Health Benefits Design

by Michael F. Murphy, MD, PhD

Page 125 of 244
Results 1241 - 1250 of 2434